SSS Sunvest Minerals Corp

Stem Cell Therapeutics Corp. (the "Company" or "SCT") (TSX VENTURE:SSS)
announces the issuance of stock options to officers and directors of the
Company. These options were issued in connection with a reduction of executive
salaries and Board of Directors' fees, all effective as of January 1, 2009.


SCT has issued an aggregate of 3,840,000 stock options to the Company's officers
and Board of Directors at an exercise price of C$0.10 per share. These options
will expire no later than February 25, 2014 subject to applicable vesting
provisions. These options were awarded in accordance with the Company's Stock
Option Plan.


About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a Canadian
public biotechnology company (TSX VENTURE:SSS) focused on the development and
commercialization of drug-based therapies to treat central nervous system
diseases. SCT is a leader in the development of therapies that utilize drugs to
stimulate a patient's own resident stem cells. The Company's programs aim to
repair neurological function lost due to disease or injury. SCT's extensive
patent portfolio of owned and licensed intellectual property supports the
potential expansion into future clinical programs in numerous neurological
diseases such as traumatic brain injury, multiple sclerosis, Huntington's
disease, Alzheimer's disease, and ALS.


For further information on Stem Cell Therapeutics Corp., visit
www.stemcellthera.com.


These securities have not been registered under the United States Securities Act
of 1933, as amended, or the securities laws of any state, and may not be offered
or sold within the United States or to, or for the account or benefit of U.S.
persons unless an applicable exemption from U.S. registration requirements is
available.


Except for historical information, this press release may contain
forward-looking statements, which reflect the Company's current expectation
regarding future events. These forward-looking statements involve risk and
uncertainties, which may cause but are not limited to, changing market
conditions, the successful and timely completion of clinical studies, the
establishment of corporate alliances, the impact of competitive products and
pricing, new product development, uncertainties related to the regulatory
approval process and other risks detailed from time to time in the Company's
ongoing quarterly and annual reporting.

Sunvest Minerals Corp (TSXV:SSS)
Historical Stock Chart
From Jun 2024 to Jul 2024

Sunvest Minerals Corp (TSXV:SSS)
Historical Stock Chart
From Jul 2023 to Jul 2024